FR2619122B1 - Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede - Google Patents

Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede

Info

Publication number
FR2619122B1
FR2619122B1 FR8711006A FR8711006A FR2619122B1 FR 2619122 B1 FR2619122 B1 FR 2619122B1 FR 8711006 A FR8711006 A FR 8711006A FR 8711006 A FR8711006 A FR 8711006A FR 2619122 B1 FR2619122 B1 FR 2619122B1
Authority
FR
France
Prior art keywords
polyosides
strains
staphylococcs
implementing
applications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR8711006A
Other languages
English (en)
French (fr)
Other versions
FR2619122A1 (fr
Inventor
Jean-Michel Fournier
Anne Bouvet
Alain Boutonnier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur filed Critical Institut Pasteur
Priority to FR8711006A priority Critical patent/FR2619122B1/fr
Priority to JP63187925A priority patent/JPH01128793A/ja
Priority to DE8888401996T priority patent/DE3875850T2/de
Priority to ES88401996T priority patent/ES2052759T3/es
Priority to AT88401996T priority patent/ATE82134T1/de
Priority to EP88401996A priority patent/EP0302781B1/fr
Priority to CA000573429A priority patent/CA1320466C/en
Priority to PT88166A priority patent/PT88166B/pt
Priority to US07/227,137 priority patent/US4902616A/en
Priority to DK198804334A priority patent/DK173564B1/da
Publication of FR2619122A1 publication Critical patent/FR2619122A1/fr
Application granted granted Critical
Publication of FR2619122B1 publication Critical patent/FR2619122B1/fr
Priority to GR920403024T priority patent/GR3006613T3/el
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/14—Streptococcus; Staphylococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/305—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F)
    • G01N2333/31—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/882—Staphylococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/882—Staphylococcus
    • Y10S435/883—Staphylococcus aureus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8711006A 1987-08-03 1987-08-03 Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede Expired - Lifetime FR2619122B1 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR8711006A FR2619122B1 (fr) 1987-08-03 1987-08-03 Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede
JP63187925A JPH01128793A (ja) 1987-08-03 1988-07-27 ブドウ球菌の莢膜性多糖類の製造方法、得られた多糖類、これらの多糖類の使用及び前記方法を実行するための菌株
CA000573429A CA1320466C (en) 1987-08-03 1988-07-29 Process for the preparation of capsular polysaccharides of staphylococci, the polysaccharides obtained, uses of these polysaccharides and strains for carrying out of the process
ES88401996T ES2052759T3 (es) 1987-08-03 1988-07-29 Procedimiento para la obtencion de poliosidos capsulares de estafilococos, aplicaciones de estos poliosidos y cepas para la puesta en practica del procedimiento.
AT88401996T ATE82134T1 (de) 1987-08-03 1988-07-29 Verfahren zur gewinnung von polyosiden aus staphylokokken-kapseln sowie verwendungen dieser polyoside und staemme fuer die durchfuehrung dieses verfahrens.
EP88401996A EP0302781B1 (fr) 1987-08-03 1988-07-29 Procédé d'obtention de polyosides capsulaires de staphylocoques, applications de ces polyosides et souches pour la mise en oeuvre du procédé
DE8888401996T DE3875850T2 (de) 1987-08-03 1988-07-29 Verfahren zur gewinnung von polyosiden aus staphylokokken-kapseln sowie verwendungen dieser polyoside und staemme fuer die durchfuehrung dieses verfahrens.
PT88166A PT88166B (pt) 1987-08-03 1988-08-01 Processo para a obtencao de poliosideos capsulares de stafilococos
US07/227,137 US4902616A (en) 1987-08-03 1988-08-02 Process for the preparation of capsular polysaccharides of staphylococci, the polysaccharides obtained, uses of these polysaccharides and strains for carrying out of the process
DK198804334A DK173564B1 (da) 1987-08-03 1988-08-03 Fremgangsmåde til fremstilling af kapselpolysaccharider fra stafylokokker, anvendelse af stammer til fremstillling af disse
GR920403024T GR3006613T3 (enExample) 1987-08-03 1992-12-21

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8711006A FR2619122B1 (fr) 1987-08-03 1987-08-03 Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede

Publications (2)

Publication Number Publication Date
FR2619122A1 FR2619122A1 (fr) 1989-02-10
FR2619122B1 true FR2619122B1 (fr) 1990-03-09

Family

ID=9353830

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8711006A Expired - Lifetime FR2619122B1 (fr) 1987-08-03 1987-08-03 Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede

Country Status (11)

Country Link
US (1) US4902616A (enExample)
EP (1) EP0302781B1 (enExample)
JP (1) JPH01128793A (enExample)
AT (1) ATE82134T1 (enExample)
CA (1) CA1320466C (enExample)
DE (1) DE3875850T2 (enExample)
DK (1) DK173564B1 (enExample)
ES (1) ES2052759T3 (enExample)
FR (1) FR2619122B1 (enExample)
GR (1) GR3006613T3 (enExample)
PT (1) PT88166B (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055455A (en) 1988-09-28 1991-10-08 Brigham And Women's Hospital Capsular polysaccharide adhesin antigen, preparation, purification and use
GB8906794D0 (en) * 1989-03-23 1989-05-10 Carroll Noel Preparation of vaccines
US7279162B1 (en) * 1990-10-22 2007-10-09 Henry M. Jackson Foundation For The Advancement Of Military Medicine Isolated broadly reactive opsonic immunoglobulin for treating a pathogenic coagulase-negative staphylococcus infection
AU681573B2 (en) * 1991-11-22 1997-09-04 Glaxosmithkline Biologicals Sa Type I and type II surface antigens associated with (staphylococcus epidermidis)
US5770208A (en) * 1996-09-11 1998-06-23 Nabi Staphylococcus aureus B-linked hexosamine antigen
US5837482A (en) * 1997-01-23 1998-11-17 Minnesota Mining And Manufacturing Company Culture medium and methods for detecting staphylococci
US6610293B1 (en) 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
US7250494B2 (en) * 1998-06-15 2007-07-31 Biosynexus Incorporated Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
US7252828B2 (en) 1998-07-15 2007-08-07 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
EP1967203A1 (en) * 1998-07-15 2008-09-10 The Brigham and Women's Hospital Polysaccharide vaccine for staphylococcal infections
US20020092987A1 (en) * 1998-09-05 2002-07-18 Taehee Cho Photo detect device using quantum dots and materialization method thereof
US6936258B1 (en) * 1999-03-19 2005-08-30 Nabi Biopharmaceuticals Staphylococcus antigen and vaccine
US7119172B2 (en) * 2001-05-21 2006-10-10 The Brigham And Women's Hospital, Inc. P. aeruginosa mucoid exopolysaccharide specific binding peptides
US6962813B2 (en) * 2001-05-21 2005-11-08 The Brigham And Women's Hospital, Inc. P. aeruginosa mucoid exopolysaccharide specific binding peptides
US7723087B2 (en) 2002-11-12 2010-05-25 The Brigham And Women's Hospital, Inc. Nucleic acid molecules for enhanced production of a bacterial polysaccharide and methods of use thereof
PT1565478T (pt) 2002-11-12 2017-11-14 The Brigham And Women`S Hospital Inc Vacina de polissacáridos para infeções estafilocócicas
CN1922489A (zh) * 2003-12-30 2007-02-28 3M创新有限公司 葡萄球菌的检测
US7399609B2 (en) * 2003-12-30 2008-07-15 3M Innovative Properties Company Staphylococcus detection
JP5080243B2 (ja) 2004-04-21 2012-11-21 ザ ブライハム アンド ウイメンズ ホスピタル， インコーポレイテッド ポリ−Ｎ−アセチルグルコサミン（ＰＮＡＧ／ｄＰＮＡＧ）結合ペプチドおよびその使用方法
AU2005286694A1 (en) * 2004-09-21 2006-03-30 The Brigham And Women's Hospital, Inc. Methods and compositions relating to mannuronic acid specific binding peptides
JP5658564B2 (ja) * 2007-08-31 2015-01-28 ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ ブドウ球菌肺疾患および状態に対する免疫に関連した方法および組成物
US9181329B2 (en) 2007-08-31 2015-11-10 The University Of Chicago Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions
KR101573648B1 (ko) 2008-07-21 2015-12-01 더 브리검 앤드 우먼즈 하스피털, 인크. 합성 베타-1,6 글루코사민 올리고당에 관한 방법 및 조성물
WO2010014304A1 (en) * 2008-07-29 2010-02-04 University Of Chicago Compositions and methods related to staphylococcal bacterium proteins
HUE026855T2 (en) 2009-04-03 2016-07-28 Univ Chicago Compositions and methods related to protein a (spa) variants
SG186290A1 (en) 2010-07-02 2013-01-30 Univ Chicago Compositions and methods related to protein a (spa) variants
BR112013024322B1 (pt) * 2011-03-22 2020-04-22 Serum Inst India Ltd processo para preparação de polissacarídeos
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
US12397014B2 (en) 2019-02-05 2025-08-26 The Brigham And Women's Hospital, Inc. Polysaccharide compositions for use in treating filariasis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123520A (en) * 1977-08-01 1978-10-31 Merck & Co., Inc. Method for preparing high molecular weight meningococcal Group C vaccine
JPS5452794A (en) * 1977-09-30 1979-04-25 Kousaku Yoshida Extracting of polysacchride from capusle containing epidermis staphylococus
US4221906A (en) * 1979-03-19 1980-09-09 American Cyanamid Company Stabilization of pneumococcal polysaccharides
FR2475900A1 (fr) * 1980-02-20 1981-08-21 Fabre Sa Pierre Complexe vaccinal contenant un antigene specifique et vaccin le contenant

Also Published As

Publication number Publication date
EP0302781B1 (fr) 1992-11-11
JPH01128793A (ja) 1989-05-22
US4902616A (en) 1990-02-20
ATE82134T1 (de) 1992-11-15
DK173564B1 (da) 2001-03-12
PT88166B (pt) 1995-07-03
DE3875850D1 (de) 1992-12-17
DE3875850T2 (de) 1993-06-09
GR3006613T3 (enExample) 1993-06-30
FR2619122A1 (fr) 1989-02-10
EP0302781A1 (fr) 1989-02-08
PT88166A (pt) 1989-06-30
ES2052759T3 (es) 1994-07-16
DK433488A (da) 1989-02-04
CA1320466C (en) 1993-07-20
DK433488D0 (da) 1988-08-03

Similar Documents

Publication Publication Date Title
FR2619122B1 (fr) Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede
MA23143A1 (fr) Procede pour la preparation de compositions vaccinantes .
FR2691326B1 (fr) Procede pour la production de composes antimicrobiens.
HUT62784A (en) Process for producing pharmaceutical compositions of elongated release, with ph-controlled membrane
RO81173A (ro) Procedeu pentru prepararea unor derivati de delta2-1,2,4-triazolin-5-ona
IT1193874B (it) Procedimento per la preparazione di una miscela polimerica,prodotti formati e lega polimerica ottenuti da essa
MA21983A1 (fr) Procede pour la preparation de derives de quinolone .
CA2084256A1 (en) Process for the preparation of 2-acetyl-1-pyrroline in encapsulated form, the intermediate compound and end product obtained
BE875183A (fr) Procede pour la preparation de 2,2,6,6-tetramethyl-4-piperidone.
FR2294185A1 (fr) Procede de preparation de l'a-epoxy-3',4' neamine et des derives d'antibiotiques aminoglycosodiques apparentes et nouveaux composes ainsi prepares
FR2330331A1 (fr) Procede d'obtention de fourrage ensile, produit et aliment obtenus par la mise en oeuvre dudit procede
BE869139A (fr) Procede pour la preparation de derives de 1,2,4-triazin-5-one et produits obtenus
EP0601721A3 (en) Process for the preparation of overbased phenates.
FR2692441B1 (fr) Procédé de production de lait stérile par microfiltration dynamique.
NL7908318A (nl) Nieuwe verbindingen met antibiotische eigenschappen, werkwijze voor de bereiding daarvan, alsmede farmaceutische preparaten die deze bevatten.
MA21984A1 (fr) Procede pour la preparation de derives de quilinone .
OA04510A (fr) Procédé de préparation d'éthers d'&-aminoacylcéphalosporine.
FR2375238A1 (fr) Procede de preparation de 7-amino substitue acetamidooxadethia-cephalosporines et nouveaux produits ainsi obtenus, a activite antibacterienne
HU902831D0 (en) Process for the production of bactericide matrixes
EP0610963A3 (en) Process for the preparation of 1,1,1,2-tetrafluoroethane.
FR2641774B3 (fr) Procede pour la preparation de zirconate de lithium, et zirconate de lithium et produits intermediaires prepares suivant celui-ci
BE875639A (fr) Procede de desinfection des hopitaux et de l'appareillage utilise a cet effet, et moyens pour sa mise en oeuvre
FR2457282A1 (fr) Nouveau derive du 1a,25 dihydroxy cholecalciferol, son procede de preparation et son application comme medicament
BE883535A (fr) Procede pour la preparation de la 2,2-dialkyl-4-methyl-5, 5-dialkyl-3-formyl-3-pyrroline, et produits ainsi obtenus
FR2331544A1 (fr) Procede de preparation de monohydrate d'ethercarboxylate et nouveau produit ainsi obtenu, utile pour la preparation de formulations detergentes

Legal Events

Date Code Title Description
ST Notification of lapse